All Vaccines

Question 1

DTaP/IPV/Hib vaccine

Answer 1

Suspension of purified high dose diphtheria
toxoid, purified tetanus toxoid, five purified components of the Bordetella pertussis bacteria, three strains of inactivated polio virus, and a purified component of Haemophilus influenzae type b bacteria attached to a tetanus toxoid carrier protein.

Question 2

PCV Pneumococcal vaccine.

Answer 2

conjugate vaccine, in which specific sugars
(polysaccharides) from the bacteria are joined to a protein (in this case, a non-toxic derivative of diphtheria). It is made from smaller pieces of the 13 types of whole bacteria . It contains a small amount of aluminium phosphate which acts as an adjuvant, strengthening and lengthening the immune response to the vaccine.

Question 3

Rotarix or Rotavirus vaccine.

Answer 3

Suspension of live attenuated rotavirus vaccine

containing a rotavirus strain of G1P[8] specificity.

Question 4

Meningitec- Meningitis vaccine.

Answer 4

Suspension of 10 micrograms meningococcal Group C oligosaccharide conjugated to 15 micrograms of diphtheria CRM197 protein.

Question 5

MMR

Answer 5

Suspension of mixture of alive attenuated virus of the 3 diseases.

Question 6

Havrix Hepatitis A vaccine.

Answer 6

Suspension of inactivated Hepatitis A virus strain HM175.

Question 7

Typhim Vi.

Answer 7

It is a sterile solution containing the cell surface
Vi polysaccharide extracted from Salmonella entericaserovarTyphi, S typhi Ty2 strain. The organism is grown in a semi-synthetic medium without animal proteins. The capsular polysaccharide is precipitated from
the concentrated culture supernatant by the addition of hexadecyltrimethylammonium bromide and the product is purified by differential centrifugation and precipitation.

Question 8

Dukoral vaccine.

Answer 8

Suspension consisting of whole killed Vibrio

cholerae cells and recombinant cholera toxin B subunit 1.

Question 9

YF VAX.

Answer 9

Culturing the 17D-204 strain of yellow fever

virus in living avian leukosis virus-free (ALV-free) chicken embryos.

Question 10

HepB.

Answer 10

Modern vaccines contain HBsAg from yeast or

mammalian cell cultures using recombinant DNA technology.

Question 11

DECAVAC.

Answer 11

Sterile suspension of alum (aluminum potassium

sulfate)-precipitated toxoids in an isotonic sodium chloride solution.

Question 12

Tdap.

Answer 12

Sterile liquid suspension of tetanus and diphtheria toxoids and acellular pertussis components adsorbed onto aluminium phosphate, for intramuscular administration.

Question 13

Hib vaccine.

Answer 13

highly purified capsular polysaccharide
(polyribosylribitol phosphate or PRP) of Haemophilus influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an outer membrane protein complex (OMPC) of the B11 strain of Neisseria meningitidis serogroup B.

Question 14

IPV vaccine.

Answer 14

Inactivated poliovirus vaccine (IPV), is based on three wild, virulent reference strains, Mahoney (type 1 poliovirus), MEF-1 (type 2 poliovirus), and Saukett (type 3 poliovirus), grown in a type of monkey kidney tissue culture (Vero cell line), which are then inactivated with formalin.

Question 15

HPV vaccine.

Answer 15

Produced using the common vaccine expression system of a yeast substrate.

Question 16

Q-VAX.

Answer 16

purified suspension of formalin-inactivated, Coxiella burnetii prepared from the strain of the microorganisms grown in the yolk sacs of embryonated eggs.

Question 17

BCG.

Answer 17

suspension of live attenuated tubercle bacillus cultivated in different nutrient substrates.

Question 18

BioThrax..

Answer 18

Made from cell-free filtrates of microaerophilic cultures of an avirulent,
nonencapsulated strain of Bacillus anthracis. The production cultures are grown in a chemically defined protein-free medium consisting of a mixture of amino acids, vitamins, inorganic salts and sugars. The final product, prepared from the sterile filtrate culture fluid contains proteins, released during the growth period and contains no dead or live bacteria.

Question 19

RabAvert.

Answer 19

obtained by growing the fixed-virus strain Flury LEP in primary cultures of chicken fibroblasts.

Question 20

Ixiaro vaccine.

Answer 20

Virus strain SA14-14-2 microorganism produced in Vero cells adsorbed on aluminium hydroxide.

Question 21

Botulism antitoxin (equine) trivalent preparation.

Answer 21

obtained from horse serum.

Question 22

Botulism antitoxin (equine) monovalent preparation.

Answer 22

obtained from horse serum.

Question 23

Diphtheria (equine) antitoxin.

Answer 23

prepared from the plasma or serum of healthy equines hyperimmunized against diphtheria toxin.

Question 24

HBIg.

Answer 24

prepared from pooled human plasma from selected donors.

Question 25

RabIg.

Answer 25

prepared from pooled human plasma from selected donors.

Question 26

TIg.

Answer 26

prepared from pooled human plasma from selected donors.

Question 27

ZIG-Zoster Ig.

Answer 27

prepared from pooled human plasma from selected donors.